Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M731Revenue $M241Net Margin (%)-26.2Altman Z-Score1.0
Enterprise Value $M931EPS $-1.5Operating Margin %-23.3Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.6Pre-tax Margin (%)-26.4Higher ROA y-yN
Price/Book5.410-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %--Current Ratio2.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-1,975.0ROA % (ttm)-13.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-39.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M42.4ROIC % (ttm)-17.8Gross Margin Increase y-yN

Gurus Latest Trades with SPNC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SPNCRon Baron 2015-06-30 Add0.13%$23.01 - $35.13
($28.04)
$ 17.21-39%Add 171.34%2,340,509
SPNCRon Baron 2015-03-31 Add0.08%$31.77 - $36.44
($34.01)
$ 17.21-49%Add 219.14%862,579
SPNCRon Baron 2014-09-30 Add0.03%$22.76 - $29.33
($27)
$ 17.21-36%Add 412.11%309,727
SPNCRon Baron 2014-06-30 Add$20.78 - $29.79
($23.2)
$ 17.21-26%Add 63.55%60,480
SPNCRon Baron 2014-03-31 Add$24.13 - $31.56
($27.26)
$ 17.21-37%Add 243.04%36,980
SPNCRon Baron 2013-12-31 Buy $17.2 - $25.43
($21.43)
$ 17.21-20%New holding10,780
SPNCGeorge Soros 2011-09-30 Sold Out -0.0012%$5.6 - $7.62
($6.51)
$ 17.21164%Sold Out0
SPNCGeorge Soros 2011-06-30 Buy $4.68 - $6.21
($5.59)
$ 17.21208%New holding13,300
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SPNC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SPNC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JENNINGS WILLIAM CDirector 2015-08-11Buy10,000$15.977.76view
Bridges Kimberly McIntoshSr VP, Sales & Mktg, VI 2015-07-29Buy3,000$16.82.44view
PELAK DANIEL ADirector 2015-07-28Buy16,000$15.5710.53view
CHILDS GUY ACFO 2015-07-28Buy5,000$15.679.83view
Matin ShahriarCOO 2015-07-28Buy5,000$15.610.32view
Bowe Wade AVice President R&D 2015-06-01Sell12,046$24.97-31.08view
BYRD AUSTIN BEVANVP, Chief Compliance Officer 2015-05-29Buy2,000$24.46-29.64view
RUGGIO JOSEPH MDirector 2015-05-22Buy2,000$24.1-28.59view
GARDON PAULSr. VP, General Counsel 2015-05-13Buy3,000$24.35-29.32view
Drake Scott WilliamPresident, CEO 2015-05-07Sell10,000$26.17-34.24view

Quarterly/Annual Reports about SPNC:

News about SPNC:

Articles On GuruFocus.com
Baron Funds Comments on The Spectranetics Corp. Aug 19 2015 
Baron Funds Comments on Spectranetics Corporation Feb 26 2014 
Spectranetics Corp. Reports Operating Results (10-Q) Nov 08 2010 
Spectranetics Corp. Reports Operating Results (10-Q) Nov 06 2009 
Spectranetics Corp. Reports Operating Results (10-Q) Aug 10 2009 
Spectranetics Corp. Reports Operating Results (10-Q) May 11 2009 
Spectranetics to Hold 2008 Fourth Quarter Financial Results Conference Call on February 19 Feb 12 2009 
Spectranetics Cross-Pilot Product Receives FDA Clearance Dec 15 2008 
Weekly CEO Buys Highlight: Spectranetics Corp., Noven Pharmaceuticals Inc., Dolan Media Company, Mod Sep 09 2008 

More From Other Websites
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Aug 28 2015
IMPORTANT SHAREHOLDER DEADLINE: Khang & Khang LLP Announces the Filing of a Securities Class Action... Aug 28 2015
Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against The Spectranetics... Aug 28 2015
SPECTRANETICS CORP Files SEC form 8-K, Other Events Aug 28 2015
Deadline Alert: The Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action... Aug 28 2015
IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against... Aug 28 2015
GPM Files Securities Class Action Lawsuit against The Spectranetics Corporation Aug 27 2015
Spectranetics Names Stacy McMahan Chief Financial Officer Aug 27 2015
SPECTRANETICS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Aug 27 2015
4:38 pm Spectranetics names Stacy McMahan Chief Financial Officer Aug 27 2015
Spectranetics Names Stacy McMahan Chief Financial Officer Aug 27 2015
Street Talk: AAP, SNDK, NNBR & SPNC Aug 18 2015
Needham: Spectranetics Isn't Just A Buy, It's Now A 'Strong Buy' Aug 18 2015
Spectranetics upgraded by Needham Aug 18 2015
Boston Scientific Corp. Earnings Q2*, 2015 Aug 10 2015
SPECTRANETICS CORP Financials Aug 07 2015
ABIOMED, Inc.: Leads amongst peers with strong fundamentals Aug 05 2015
10-Q for The Spectranetics Corp. Aug 01 2015
SPECTRANETICS CORP Files SEC form 10-Q, Quarterly Report Jul 30 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Spectranetics Corp. and Its... Jul 30 2015
Spectranetics to Present at the Canaccord Genuity Growth Conference Jul 29 2015
Spectranetics to Present at the Canaccord Genuity Growth Conference Jul 29 2015
Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of... Jul 29 2015
Investigation of The Spectranetics Corporation Announced by The Law Offices of Howard G. Smith Jul 27 2015
Spectranetics reports 2Q loss Jul 23 2015
Spectranetics Reports Second Quarter Financial Results Jul 23 2015
Spectranetics to Hold 2015 Second Quarter Financial Results Conference Call on July 23, 2015 Jul 09 2015
Spectranetics Receives FDA 510(k) Clearance for Larger Diameter AngioSculpt(R) Scoring Balloon... Jun 24 2015
Spectranetics to Participate in Upcoming Investor Conferences Apr 30 2015
Spectranetics reports 1Q loss Apr 23 2015
Spectranetics Accelerates Investment in Stellarex(TM) Drug- Coated Balloon Platform for Treatment of... Apr 23 2015
Spectranetics' Stellarex(TM) Drug-coated Balloon Clinical Findings Published in Catheterization and... Apr 16 2015
Spectranetics to Hold 2015 First Quarter Financial Results Conference Call on April 23 Apr 13 2015
Spectranetics Announces Chief Financial Officer Transition Mar 18 2015
Spectranetics Appoints Todd C. Schermerhorn as Director Mar 12 2015
Spectranetics reports 4Q loss Feb 19 2015
Spectranetics Achieves Fourth Quarter 2014 Revenue of $63.0 Million Feb 19 2015
Prudential Retirement adds new clients Hubbard Construction and The Spectranetics Corporation Feb 18 2015
Spectranetics to Present at the J.P. Morgan 33rd Annual Healthcare Conference Dec 29 2014
Spectranetics Outlines Growth Opportunities at Analyst & Investor Meeting Dec 04 2014
Spectranetics to Host Investor & Analyst Meeting Nov 17 2014
Spectranetics to Participate in Upcoming Investor Conferences Nov 05 2014
Spectranetics to Acquire Stellarex™ Drug Coated Balloon Assets From Covidien Nov 02 2014
Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien Nov 02 2014
Spectranetics beats Street 3Q forecasts Oct 23 2014
Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million Oct 23 2014

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK